Is your investment portfolio feeling a little dull? This week could be your chance to spice things up. Eight SME IPOs are set to make their stock market debut, collectively aiming to raise a substantial ₹409 crores. From infrastructure to education, there’s something for every investor.
We’ve already dived into RNFI Services and SAR Televenture, the first two out of the gate. But the excitement doesn’t stop there. VVIP Infratech, V.L. Infraprojects, Manglam Infra and Engineering, Chetana Education, Aprameya Engineering, and Clinitech Laboratory are all gearing up to capture investor attention.
Let’s break down the numbers, the business models, and the market buzz surrounding these IPOs.
VVIP Infratech Ltd
Offer Price | ₹91 – ₹93 per share |
Face Value | ₹10 per share |
Opening Date | 23 July 2024 |
Closing Date | 25 July 2024 |
Total Issue Size (in Shares) | 6,582,000 |
Total Issue Size (in ₹) | ₹61.21 Cr |
Issue Type | Book Built Issue IPO |
Lot Size | 1200 Shares |
Listing at | BSE SME |
VVIP Infratech is planning to raise funds through a fresh issue IPO. No existing shares are being offered. To invest in this IPO, you must buy at least 1200 shares, which will cost you ₹1,11,600. Retail investors can’t invest more than this. Bigger investors (HNI and NII) can buy at least 2400 shares. There’s no upper limit for big investors and institutional investors.
Objectives of the IPO
VVIP Infratech plans to use the money raised from the IPO for these purposes:
- Spending on new projects
- Managing day-to-day operations
- General corporate expenses
- Covering IPO-related costs
GMP
The current Grey Market Premium (GMP) is ₹47. It means people will pay ₹47 extra to get the shares. If the IPO is priced at the upper end of the price band (₹93), the expected listing price would be ₹140. This indicates a potential gain of 50.54%. However, remember, GMP is just an estimate and doesn’t guarantee the actual listing price.
Company Overview
VVIP Infratech is a construction company specializing in building water treatment plants, roads, and electrical infrastructure. It mainly operates in Uttar Pradesh, Uttarakhand, Delhi, and other northern Indian states. The company has a strong track record of completing projects on time and within budget. It has worked with big clients like Ghaziabad Development Authority and Uttarakhand Power Corporation.
Financials
VVIP Infratech has shown impressive growth in recent years. Revenue grew by 35.77%, and profit increased by 52.56% in the last financial year compared to the previous year.
SWOT Analysis
STRENGTHS | WEAKNESSES |
Established track record (founded in 2001) Experience in focused infrastructure projects Strong presence in North India Expertise in sewer treatment projects | Reliance on government contracts Limited geographical presence Competition from larger players |
OPPORTUNITIES | THREATS |
Government’s focus on infrastructure development Increasing demand for water treatment plants Potential for expansion into new regions | Economic slowdown impacting infrastructure spending Rising raw material prices Delay in project approvals |
V. L. Infraprojects Ltd
Offer Price | ₹39 – ₹42 per share |
Face Value | ₹10 per share |
Opening Date | 23 July 2024 |
Closing Date | 25 July 2024 |
Total Issue Size (in Shares) | 4,410,000 |
Total Issue Size (in ₹) | ₹18.52 Cr |
Issue Type | Book Built Issue IPO |
Lot Size | 3000 Shares |
Listing at | NSE SME |
The company is offering 44.1 lakh shares to the public at an upper price band of ₹42 per share. This fresh issue aims to raise ₹18.52 crore for the company. As no existing shares are being offered for sale, the entire IPO comprises this fresh issue. Additionally, 2.4 lakh shares have been reserved for market makers to ensure liquidity in the stock post-listing.
Objectives of the IPO
The company plans to use the money raised from the IPO for:
- Managing day-to-day operations
- General corporate expenses
GMP
The Grey Market Premium (GMP) is ₹40. It means people will pay ₹40 extra to get the shares. If the IPO is priced at ₹42, the expected listing price would be ₹82. That’s a potential gain of 95.24%. But remember, this is just an estimate.
Company Overview
V.L. Infraprojects is a construction company specializing in water supply and wastewater projects. It handles everything from planning to building and starting up these projects. The company also offers maintenance services for water pipelines. It has approvals from various government departments.
Financials
V.L. Infraprojects has seen impressive growth. Their revenue grew by a whopping 149.72% in the last financial year compared to the previous year, and their profit also jumped by 175.76%.
SWOT Analysis
STRENGTHS | WEAKNESSES |
Focus on a growing sector (water infrastructure) Integrated service offerings Strong financial performance | Relatively new company (incorporated in 2014) Dependence on government projects Geographical concentration |
OPPORTUNITIES | THREATS |
Growing demand for water infrastructure Expansion into new geographical areas Potential for offering additional services | Intense competition Economic slowdown impacting government spending Changes in government policies |
Manglam Infra and Engineering Ltd
Offer Price | ₹53 – ₹56 per share |
Face Value | ₹10 per share |
Opening Date | 24 July 2024 |
Closing Date | 26 July 2024 |
Total Issue Size (in Shares) | 4,932,000 |
Total Issue Size (in ₹) | ₹27.62 Cr |
Issue Type | Book Built Issue IPO |
Lot Size | 2000 Shares |
Listing at | NSE SME |
Manglam Infra and Engineering offers 49.32 lakh shares to the public at an upper price band of ₹56 per share. This fresh issue aims to raise ₹27.62 crore for the company. As no existing shares are being offered for sale, the entire IPO comprises this fresh issue. To invest, you must buy a minimum of 2000 shares, which costs ₹112,000.
Objectives of the IPO
The funds from the IPO will be used to manage the company’s day-to-day operations and general corporate purposes.
GMP
The market sentiment for the Manglam Infra and Engineering IPO is cautiously optimistic. The Grey Market Premium (GMP) is currently ₹10. It means people will pay ₹10 extra to get the shares. If the IPO is priced at the upper end, the expected listing price would be ₹66. This indicates a potential gain of 17.86%. However, it’s essential to remember that GMP is just an estimate.
Company Overview
Manglam Infra and Engineering is a consultancy firm that offers infrastructure and engineering services. Its team of over 300 professionals works on highways, roads, bridges, buildings, water resources, and waste management projects. The company works with both private and government clients.
Financials
Manglam Infra and Engineering has shown steady growth. Their revenue increased by 16.46% in the last financial year compared to the previous year, and their profit also grew by 22.06% during the same period.
SWOT Analysis
STRENGTHS | WEAKNESSES |
Established experience (founded in 2010), it offers a broad range of infrastructure and engineering consultancy services Experience working with private and government clients with PAN India presence as engineering consultant Team of over 300 professionals with expertise across various disciplines. | Reliance on a limited number of clients (both government and private) Competition from established engineering consultancies |
OPPORTUNITIES | THREATS |
Growing demand for infrastructure development in India Potential to expand service offerings into new areas Opportunity to expand geographically | Economic slowdown impacting infrastructure spending Changes in government regulations Loss of key personnel |
Chetana Education Ltd.
Offer Price | ₹80 – ₹85 per share |
Face Value | ₹10 per share |
Opening Date | 24 July 2024 |
Closing Date | 26 July 2024 |
Total Issue Size (in Shares) | 5,400,000 |
Total Issue Size (in ₹) | ₹45.90 Cr |
Issue Type | Book Built Issue IPO |
Lot Size | 1600 Shares |
Listing at | NSE SME |
Chetana Education is raising ₹45.90 crore through a fresh issue of 54 lakh shares at an upper price band of ₹85 per share. The IPO is divided among investors: 50% for institutional buyers, 35% for retail investors, and 15% for high-net-worth individuals and non-institutional investors.
Objectives of the IPO
This IPO aims to raise funds for strategic objectives:
- Repay existing debt
- Manage day-to-day operations
- Support general corporate purposes
GMP
The market is showing moderate interest in the Chetana Education IPO. The Grey Market Premium (GMP) is currently ₹11. This GMP means people are willing to pay ₹11 extra to get the shares. If the IPO is priced at the upper end, the expected listing price would be ₹96. That’s a potential gain of 12.94%. However, it’s important to remember that GMP is just an estimate.
Company Overview
Chetana Education is a textbook publishing company focused on the K-12 segment for the Maharashtra State Board and CBSE. It also offers educational software and videos. The company has a strong presence in the market, with over 60 lakh books sold and a portfolio of 700 titles under 15 different brands.
Financials
Chetana Education has shown impressive growth. Revenue increased by 23.89% in the last financial year compared to the previous year, and profit grew significantly by 75.57% during the same period.
SWOT Analysis
STRENGTHS | WEAKNESSES |
Strong presence in the K-12 textbook market Diversified product offerings (textbooks, software, videos) Strong financial performance | Dependence on government curriculum and policies Competition from established players in the education sector |
OPPORTUNITIES | THREATS |
Growing education sector in India Expansion into new markets and segments Potential for digital product expansion | Increasing paper costs and printing expenses Changes in government policies affecting the education sector Competition from online education platforms |
Aprameya Engineering Ltd.
Offer Price | ₹56 – ₹58 per share |
Face Value | ₹10 per share |
Opening Date | 25 July 2024 |
Closing Date | 29 July 2024 |
Total Issue Size (in Shares) | 5,040,000 |
Total Issue Size (in ₹) | ₹29.23 Cr |
Issue Type | Book Built Issue IPO |
Lot Size | 2000 Shares |
Listing at | NSE SME |
Objectives of the IPO
The funds raised from the IPO will be used for:
- Increasing working capital
- General corporate expenses
GMP
The Grey Market Premium (GMP) for Aprameya Engineering IPO hasn’t been announced yet. This means there’s no current market estimate of the potential listing price.
Company Overview
Aprameya Engineering is a company focused on the healthcare sector. Established in 2003, it specializes in setting up and maintaining critical care units, such as ICUs, NICUs, and PICUs, as well as operation theaters. Additionally, the company supplies essential medical equipment to hospitals, doctors, and diagnostic centers.
Aprameya’s core business is divided into two main areas:
- Healthcare infrastructure development involves designing, installing, and maintaining critical care units and operation theaters in hospitals and medical facilities.
- Medical equipment supply: The company offers a range of high-quality medical equipment, including patient monitoring systems, cardiology equipment, and radiology equipment.
Financials
Aprameya Engineering has faced challenges in recent years. Their revenue decreased by 16.23% in the last financial year compared to the previous year, and their profit dropped by 35.62%.
SWOT Analysis
STRENGTHS | WEAKNESSES |
Established track record (founded in 2003) Expertise in setting up critical care units and operation theaters Experience in supplying medical equipment to a wide range of clients Strong customer relationships | The recent decline in revenue and profitability Dependence on government spending in the healthcare sector Limited geographical presence (focus on Rajasthan) |
OPPORTUNITIES | THREATS |
Growing demand for healthcare infrastructure in India Expansion into new markets and service offerings Potential for government initiatives to boost healthcare spending | Competition from other healthcare infrastructure companies Fluctuations in prices of medical equipment Changes in government regulations |
Clinitech Laboratory Ltd.
Offer Price | ₹96 per share |
Face Value | ₹10 per share |
Opening Date | 25 July 2024 |
Closing Date | 29 July 2024 |
Total Issue Size (in Shares) | 602,400 |
Total Issue Size (in ₹) | ₹5.78 Cr |
Issue Type | Fixed Price Issue IPO |
Lot Size | 1200 Shares |
Listing at | BSE SME |
Clinitech Laboratory is raising ₹5.78 crore through a fresh issue of 6.024 lakh shares at an upper price band of ₹96 per share. The entire IPO is a fresh issue, with no existing shares being offered for sale.
Objectives of the IPO
The funds raised from the IPO will be used for:
- Expansion of Diagnostic Centres
- General corporate expenses
GMP
The Grey Market Premium (GMP) for the Clinitech Laboratory IPO hasn’t been announced yet, and there is no current market estimate of the potential listing price.
Company Overview
Clinitech Laboratory Limited is a diagnostic service provider with a strong foothold in the Thane and Navi Mumbai region. Established in 1990, the company specializes in various diagnostic tests, including biochemistry, immunology, hematology, molecular biology, serology, microbiology, and histopathology. With a network of eight diagnostic centers, Clinitech Laboratory is well-positioned to cater to the healthcare needs of the local population.
A key highlight of the company is its commitment to quality and accuracy. All its centers are accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL), ensuring adherence to stringent quality standards. This focus on quality has helped Clinitech build trust among patients and healthcare professionals alike.
Financials
Clinitech Laboratory’s financial performance has been mixed. While their revenue saw a slight increase of 1.19% in the last financial year, their profit after tax dropped by a significant 39.46%.
SWOT Analysis
STRENGTHS | WEAKNESSES |
Established track record (founded in 1990) Broad range of diagnostic tests offered (over 150) NABL-accredited laboratories ensuring quality and safety Experienced staff (85 employees) | Limited geographical presence (Thane and Navi Mumbai only) Recent decline in profitability (-39.46% PAT) Dependence on existing diagnostic centers for revenue growth |
OPPORTUNITIES | THREATS |
Growing demand for diagnostic services in India Expansion into new geographical areas Potential for growth in new diagnostic test categories | Competition from other diagnostic laboratories Changes in government regulations for diagnostic services Changes in government regulations for diagnostic services |
Conclusion
With eight companies vying for investor attention and a collective target of ₹409 crores, this week’s SME IPO market is undeniably buzzing. As we delve deeper into the financials, growth prospects, and market sentiment surrounding these companies, it’s crucial to remember that investing in IPOs, especially those from SMEs, carries inherent risks. While these companies offer the potential for high returns, thorough due diligence is essential before making any investment decisions.
*Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This article is for education purposes only and shall not be considered as recommendation or investment advice by Research & Ranking. We will not be liable for any losses that may occur. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, membership of BASL, and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.
Know more about
IPO | Current IPO | Upcoming IPO | Listed IPO
How useful was this post?
Click on a star to rate it!
Average rating 0 / 5. Vote count: 0
No votes so far! Be the first to rate this post.
waitfor delay '0:0:5'--
I’m Archana R. Chettiar, an experienced content creator with
an affinity for writing on personal finance and other financial content. I
love to write on equity investing, retirement, managing money, and more.